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I read the article by Tang et al entitled ‘Can probiotics be
used to treat allergic diseases?’ with great interest.1 Sub-
sequent to my review, I deemed it necessary to contribute my
opinion regarding some of the conflicting issues mentioned in
the article. The authors did not point out several of the pro-
biotics’ effects on the mechanisms affecting allergy develop-
ment. For instance, their direct effect on the maturing gut
barrier (intestinal mucosa structure/function) and development
of tolerogenic dendritic cells resulting in transformation of the
local intestinal and systemic immune response.2 These
favorable effects elicited by probiotics in allergic children are
consistent with the current concept of “nutritional immunol-
ogy”,3 which explains not only the treatment of allergic
symptoms but the concept of developing tolerance as well.4
These and other related mechanisms are explained in detail
in one of our articles.2
The role of probiotics on allergic airway diseases e.g.,
asthma and allergic rhinitis (AR), remains controversial. As
stated in the article, none of the primary prevention studies
demonstrated that probiotics have any effect in the develop-
ment of asthma in humans.1 However, there are also several
studies which reportedly did show the therapeutic effect of
probiotics on asthma management. In a randomized, placebo-
controlled, double-blind pilot study, 17 children aged 6e12
years with intermittent or mild persistent asthma were enrol-
led. There were eight patients who received laser acupuncture
treatment for 10 weeks and probiotic treatment (Enterococcus
faecalis) for 7 weeks. This interactive treatment of probiotics
demonstrated a beneficial clinical effect on bronchial hyper-
reactivity, and could be helpful in the prevention of asthma
exacerbations.5 In another randomized, double-blind, placebo-
controlled study of school children (age 6e12 years) with
asthma and AR, the aim was to determine whether daily
supplementation with specific Lactobacillus gasseri A5 for 8
weeks can improve the clinical symptoms and immunor-
egulatory changes. The pulmonary function and clinical
symptom scores for asthma and AR improved. Additionally,
significant reduction in the TNF-a, IFN-g, IL-12, and IL-13
levels were also shown.6cts of interest: The authors declare that there are no conflicts of interest
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in blood or immunologic parameters of AR in the probiotic
groups of the PubMed database.1 As mentioned above, there
are quite a few studies demonstrating significant change in
blood and/or immunologic parameters of AR patients sup-
plemented with probiotics. Intranasally delivered probiotic
mixture VSL#3 prevented the development of Parietaria major
allergen-specific response, by downregulating Th2 responses
at the local and systemic level.7 Consistent with this study,
intranasal administration of Lactobacillus plantarum sup-
pressed allergen-induced Th1 and Th2 immune responses
(both IFN-g and IL-5 production) in house dust mite Der p1-
sensitized animals.8
Another issue regarding the safety of probiotics is data
from the literature, that suggest authors have insufficient proof
to support the safety of probiotic use in healthy newborns.1
The safety of Bifidobacterium lactis has been established in
newborns and in vulnerable infants, e.g., preterms, malnour-
ished, and infants born to mothers with HIV disease. Addi-
tionally, Bifidobacterium lactis is the only probiotic that has
undergone Food and Drug Administration evaluation for use in
commercial infant formulas.2,9 Moreover, Lactobacillus GG is
one of the probiotics with the greatest volume of clinical and
experimental evidence regarding its possible effects on
pediatric allergic diseases. Lactobacillus GG has a history of
safe use exceeding 25 years, which includes administration to
preterm infants.4 Lactobacillus GG also appears to generally
be safe as an appropriate probiotic for older infants and chil-
dren.2 In conclusion, the need to select the most beneficial
probiotic strain (dose and timing of supplementation) as well
as the susceptible subgroups of allergic diseases, still need to
be determined.References
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